Skip to main content

and
  1. Article

    Open Access

    A randomized, double-blind, placebo-controlled, parallel-group study of once-daily inhaled fluticasone furoate on the hypothalamic–pituitary–adrenocortical axis of children with asthma

    To evaluate the effects of fluticasone furoate on the hypothalamic–pituitary–adrenocortical axis, and the safety and tolerability of fluticasone furoate treatment in children with asthma.

    Philippe Bareille, Susan Tomkins, Varsha Imber in Allergy, Asthma & Clinical Immunology (2020)

  2. Article

    Open Access

    Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trial

    Fluticasone furoate/Vilanterol trifenatate (FF/VI) is an inhaled corticosteroid/long-acting beta-agonist combination with a prolonged bronchodilator duration of action. We characterised the time-course of onse...

    George Bardsley, Peter Daley-Yates, Amanda Baines, Rodger Kempsford in Respiratory Research (2018)